Evidence-based medicine suggests that medical decision-making should weigh scientific evidence, physician experience and the individual patient's medical history. CHI is concerned that cost-driven health care policies are being advanced to limit the use of innovative medical technologies and to deny patients treatment.
Please join CHI every other Wednesday as we bring you a new episode of the five-part podcast series, Cost Over Care: The Dangers of Bureaucratic Medicine. In this series, leading health policy experts will explore how applying cost-effectiveness analysis to health care coverage decisions limits patients' access to innovative therapies.
